Latest news

9th April 2018

BioGaia continues to invest in MetaboGen

On April 6 2018, BioGaia announced its decision to acquire additional shares in MetaboGen and is now investing SEK 11.7 million in shares (...) Read the full story

Contact us

MetaboGen AB

AZ BioVentureHub, HE424
c/o AstraZeneca R&D Mölndal
431 83 Mölndal

Visiting Address

Erik Dahlbergsgatan 11A
412 96 Göteborg
Sweden

Name *
Company *
E-mail *
Phone
Message *
Fields marked with * are mandatory.

Latest news

9th April 2018

BioGaia continues to invest in MetaboGen

On April 6 2018, BioGaia announced its decision to acquire additional shares in MetaboGen and is now investing SEK 11.7 million in shares (...) Read the full story

  • Metabogen
    Technology

    MetaboGen has built a platform that integrates top-of-the line metagenomic data analysis with strain identification and subsequent development as well as clinical programs, to ensure successful development of novel assets.

  • Pharmaceutical
    Industry

    By using our platform, we provide great opportunities for integrating metagenomic analysis into translational parts of pharmaceutical development.

  • Next Generation
    Probiotics

    Thorough investigation of the microbiome and identification of bacterial strains provides the probiotic industry with new tools for more precise product development.